Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20009341HPVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS20068329HPVENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS44006869HTLV-1ENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TVIS44004202HTLV-1ENSG00000116478.13protein_codingHDAC1YesNo3065Q13547
Q6IT96
TCGA Plot Options
Drug Information
GeneHDAC1
DrugBank IDDB06603
Drug NamePanobinostat
Target IDBE0008667
UniProt IDQ9UKV0
Regulation Typeinhibitor
PubMed IDs17455259; 17145876; 26848406
CitationsBeckers T, Burkhardt C, Wieland H, Gimmnich P, Ciossek T, Maier T, Sanders K: Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group. Int J Cancer. 2007 Sep 1;121(5):1138-48.@@Geng L, Cuneo KC, Fu A, Tu T, Atadja PW, Hallahan DE: Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer. Cancer Res. 2006 Dec 1;66(23):11298-304.@@Favreau AJ, McGlauflin RE, Duarte CW, Sathyanarayana P: miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications. Exp Hematol Oncol. 2016 Feb 3;5:4. doi: 10.1186/s40164-016-0033-6. eCollection 2015.
GroupsApproved; Investigational
Direct ClassificationTryptamines and derivatives
SMILESCC1=C(CCNCC2=CC=C(C=CC(=O)NO)C=C2)C2=CC=CC=C2N1
Pathways
PharmGKBPA166161307
ChEMBLCHEMBL483254